Rani Therapeutics Holdings (RANI) Research & Development (2020 - 2026)
Rani Therapeutics Holdings (RANI) reported Research & Development of $5.02 million for Q2 2026, down 8.9% from $5.51 million a year earlier and down 2.8% from the prior quarter.
Rani Therapeutics Holdings (RANI) Research & Development (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Rani Therapeutics Holdings' Research & Development came in at $18.31 million, down 26.9% year-over-year; for FY2025, it came in at $20.21 million, down 24.3% from FY2024.
- Research & Development has a five-year compound annual growth rate of 10.9% (FY2020 to FY2025).
- By year, Research & Development came in at $26.68 million in FY2024 (-32.7%), $39.62 million in FY2023 (+8.2%), $36.61 million in FY2022 (+38.2%) and $26.48 million in FY2021 (+119.9%).
- Five-year quarterly Research & Development spans a low of $3.22 million in Q3 2025 and a high of $11.96 million in Q3 2021.
- Year over year, Research & Development has now declined in each of the last 11 quarters, with an average decline of 23.1% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q3 2021 (growth of 472.2%); the low point was Q3 2025 (a decline of 47.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.16 million (Q1 2026), $4.91 million (Q4 2025) and $3.22 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Rani Therapeutics Holdings | 147.86 Mn | 156.61 Mn | - | 5.02 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.02 Mn |
| Mar 31, 2026 | 5.16 Mn |
| Dec 31, 2025 | 4.91 Mn |
| Sep 30, 2025 | 3.22 Mn |
| Jun 30, 2025 | 5.51 Mn |
| Mar 31, 2025 | 6.57 Mn |
| Dec 31, 2024 | 6.81 Mn |
| Sep 30, 2024 | 6.17 Mn |
| Jun 30, 2024 | 6.12 Mn |
| Mar 31, 2024 | 7.59 Mn |
| Dec 31, 2023 | 7.61 Mn |
| Sep 30, 2023 | 11.22 Mn |
| Jun 30, 2023 | 11.09 Mn |
| Mar 31, 2023 | 9.71 Mn |
| Dec 31, 2022 | 10.39 Mn |
| Sep 30, 2022 | 9.10 Mn |
| Jun 30, 2022 | 9.53 Mn |
| Mar 31, 2022 | 7.59 Mn |
| Dec 31, 2021 | 7.42 Mn |
| Sep 30, 2021 | 11.96 Mn |
Rani Therapeutics Holdings Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=RANI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "RANI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=RANI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();